Literature DB >> 1716591

Effect of exogenous recombinant human granulocyte and granulocyte-macrophage colony-stimulating factor on neutrophil function following allogeneic bone marrow transplantation.

I Fabian1, Y Kletter, I Bleiberg, M Gadish, E Naparsteck, S Slavin.   

Abstract

Functional activity of peripheral blood granulocytes was assessed in seven patients and in their normal donors following allogeneic bone marrow transplantation (BMT). Functions studied included superoxide generation (O2-), intracellular killing of Staphylococcus aureus, phagocytosis, and killing of Candida albicans. Neutrophils were tested following preincubation with 300 pM granulocyte-macrophage colony-stimulating factor (GM-CSF), 1.2 nM granulocyte colony-stimulating factor (G-CSF), or buffered solution (diluent) as control. Our data indicate that following BMT, both recipients and their normal donors show GM-CSF- and G-CSF-induced increases in: 1) O2- production in response to fMet-Leu-Phe (fMLP), 2) killing of S. aureus, and 3) phagocytosis of C. albicans. In two patients that showed low candidacidal activity, GM-CSF and G-CSF markedly enhanced the cytotoxic activity of the cells. Our studies indicate that GM-CSF and G-CSF increase "oxygen-dependent" oxidative activities in neutrophils from BMT recipients and their normal donors and enhance the antimicrobial activity of the cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1716591

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  5 in total

1.  Recombinant Granulocyte-Macrophage Colony-Stimulating Factor (rGM-CSF) : A Review of its Pharmacological Properties and Prospective Role in the Management of Myelosuppression.

Authors:  Susan M Grant; Rennie C Heel
Journal:  Drugs       Date:  1992-04       Impact factor: 9.546

Review 2.  Immune reconstitution post allogeneic transplant and the impact of immune recovery on the risk of infection.

Authors:  Rohtesh S Mehta; Katayoun Rezvani
Journal:  Virulence       Date:  2016-07-06       Impact factor: 5.882

3.  A kindred with Griscelli disease: spectrum of neurological involvement.

Authors:  H Hurvitz; R Gillis; S Klaus; A Klar; F Gross-Kieselstein; E Okon
Journal:  Eur J Pediatr       Date:  1993-05       Impact factor: 3.183

4.  Synergy of simultaneous administration of ofloxacin and granulocyte colony-stimulating factor in killing of Escherichia coli by human neutrophils.

Authors:  A Kropec; S W Lemmen; H J Grundmann; I Engels; F D Daschner
Journal:  Infection       Date:  1995 Sep-Oct       Impact factor: 3.553

5.  Combined effect of human neutrophils, ceftazidime and granulocyte colony-stimulating factor on killing of Escherichia coli.

Authors:  F D Daschner; H Grundmann; K Anding; S Lemmen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-06       Impact factor: 3.267

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.